Anteo Diagnostics (ASX:ADO) is a surface coating company with a proprietary family of enabling chemistries, called Mix&Go. Mix&GoTM enables the fast and easy production of superior surfaces for the biotechnology, diagnostics and pharmaceutical industries.
Our Mix&Go family of protein binding chemistries is gaining traction with a wide spectrum of clients in the in vitro diagnostics industry including bead manufacturers, test developers, test manufacturers, and life science companies.
The company evolved from Bio-Layer Corporation Ltd (ASX:BLS), an Australian material science company, which was established in 1999 as privately held Polymerat and listed on the ASX through a reverse acquisition by SSH Medical (ASX:SSH) in October of 2005. The company initially worked on surface chemistry for proteomics tools and then focused its efforts on immunoassays and related applications used in diagnostics. In 2008, the Company was renamed Anteo Diagnostics, derived from the Latin word for "anticipate, prevent, precede", reflecting the company’s approach to diagnostics opportunities. Mix&Go technology has been extensively validated over many years. So far Anteo Dx has entered into commercial licences with Life Technologies, Bangs Laboratories, Merck KGaA and eBioscience.
Anteo Dx is headquartered in a state-of-the art laboratory space in the Brisbane Technology Park, Brisbane, Australia. Anteo currently employs approximately 20 people.
Anteo Dx has developed Mix&Go, a proprietary “molecular glue” which makes the attachment of biomolecules to synthetic surfaces faster, easier and less costly.